SCHEMBL13005779

SCHEMBL13005779

COC(=O)/C=[N+](\[O-])Cc1ccccc1I

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
POLB P06746 1/20 0.36
RAB9A P51151 1/20 0.36
IDO1 P14902 2/20 0.34
ALDH1A1 P00352 4/20 0.34
MAPT P10636 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
HPGD P15428 2/20 0.34
MEN1 O00255 1/20 0.34
HSP90AA1 P07900 1/20 0.34
MAPK1 P28482 1/20 0.34
CACNA1B Q00975 1/20 0.34
APBA1 Q02410 1/20 0.34
KMT2A Q03164 1/20 0.34
NLRP1 Q9C000 1/20 0.34
SIRT1 Q96EB6 1/20 0.33
SIGMAR1 Q99720 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6045284 0.81 CYP1A2 (0.41) CYP1A2CYP2D6CYP2C9CYP2C19IDO1
SCHEMBL6045280 0.81 CYP1A2 (0.41) CYP1A2CYP2D6CYP2C9CYP2C19IDO1
SCHEMBL13005774 0.81 CYP1A2 (0.41) CYP1A2CYP2D6CYP2C9CYP2C19IDO1
SCHEMBL10265250 0.78 MEN1 (0.36) POLBRAB9AALDH1A1MAPTNPSR1
SCHEMBL10209695 0.77 TLR4 (0.40) POLBRAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL12530396 0.74 TRPV1 (0.40) CYP1A2CYP2D6CYP2C19RAB9AIDO1
SCHEMBL10209484 0.73 NFE2L2 (0.31)
SCHEMBL12718963 0.72 MAPT (0.36) POLBRAB9AALDH1A1MAPTNPSR1
SCHEMBL14970045 0.71 KMT2A (0.34) CYP1A2CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL8594194 0.70 L3MBTL1 (0.40) POLBIDO1ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed